MORSE Consulting’s Sherry O’Quinn will be presenting on “Payer budget management” at the CORD GETTING TO ACCESS event in Vancouver.


Why this forum matters: Innovative drug therapies are medicines that can:

Offer a substantial improvement over existing therapies; for example, biologics can modify the underlying cause of a condition rather than just treat the symptoms;

Address an unmet need; many drugs for rare disease are the first to be developed for that condition

Target the (unique) characteristics of a subgroup of patients based on genetic makeup and/or other individual characteristics

Cure the disease; for example, by eliminating the cause (hepatitis C virus), replacing abnormal cells (stem cell replacement), or modifying the faulty gene But innovative therapies come at a price that is often considered “unaffordable” under current assessment processes

Individual high-cost therapies can have an identifiable impact on overall drug plan budgets, whether private or public

Updated Draft Agenda

Individual Registration:

  • $995 early bird rate (extended to March 12)
  • $1250 regular rate (after March 12)
Patient Registration:
  • $495 early bird rate (extended to March 12)
  • $650 regular rate (after March 12)

If you are a patient representative who would like to attend the forum but need financial assistants to cover the registration fee, please email us at

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Please wait...

Please leave these two fields as-is: